MicroRNA-27b-3p Promotes Tumor Progression and Metastasis by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Triple-Negative Breast Cancer

Gain Fat—Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis

(2019) Dana Ishay-Ronen et al.   CANCER CELL

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment

(2019) Ana C. Garrido-Castro et al.   Cancer Discovery

Aryl hydrocarbon-estrogen alpha receptor-dependent expression of miR-206, miR-27b, and miR-133a suppress cell proliferation and migration in MCF-7 cells

(2019) Keivan Mobini et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer

(2019) Khaled et al.   Cancers

miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study

(2019) Bethany N. Hannafon et al.   BMC CANCER

MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer

(2019) Lei Ding et al.   Cells

Triple negative breast cancer: A thorough review of biomarkers

(2019) Jesse Lopes da Silva et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer

(2018) Steven C. Eastlack et al.   Molecular Cancer

miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells

(2018) Danni Chen et al.   Cell Death & Disease

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

(2017) Carsten Denkert et al.   LANCET

MicroRNAs in the prognosis of triple-negative breast cancer

(2017) Lingshuang Lü et al.   MEDICINE

MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3

(2016) Xiunan Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

EMT: 2016

(2016) M. Angela Nieto et al.   CELL

HIC1 and miR-23~27~24 clusters form a double-negative feedback loop in breast cancer

(2016) Yanbo Wang et al.   CELL DEATH AND DIFFERENTIATION

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression

(2016) Daniela Rovito et al.   Oncotarget

Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus

(2016) Chin-Hsiao Tseng   Oncotarget

Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes

(2015) Yan Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells

(2015) SHIMENG ZHANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

The MicroRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-suppressive Gene Prosaposin

(2014) Brian Ell et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status

(2014) Songjie Shen et al.   PLoS One

6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ)

(2013) Boon Shing Tan et al.   CANCER LETTERS

Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF-  in Breast Cancer

(2013) L. Jin et al.   CANCER RESEARCH

MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells

(2011) J-J Lee et al.   ONCOGENE

Repression of NHE1 Expression by PPAR  Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo

(2009) A. P. Kumar et al.   CANCER RESEARCH

ST14(Suppression of Tumorigenicity 14) Gene Is a Target for miR-27b, and the Inhibitory Effect of ST14 on Cell Growth Is Independent of miR-27b Regulation

(2009) Yanfang Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Suppression of Tumor Formation by a Cyclooxygenase-2 Inhibitor and a Peroxisome Proliferator-Activated Receptor   Agonist in an In vivo Mouse Model of Spontaneous Breast Cancer

(2008) A. Mustafa et al.   CLINICAL CANCER RESEARCH

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

(2008) L.-X. Yan et al.   RNA

PPARγand PPARδas Modulators of Neoplasia and Cell Fate

(2008) Robert I. Glazer et al.   PPAR Research